VEGF, VEGF165b and EG-VEGF: Expression is specifically related with hormone profile in pituitary adenomas
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
720 0
SM ISO690:2012
CORLAN, Ana Silvia, CIMPEAN, Anca-Maria, MELNIC, Eugen, RAICA, Marius, SÂRB, Simona. VEGF, VEGF165b and EG-VEGF: Expression is specifically related with hormone profile in pituitary adenomas. In: European Journal of Histochemistry, 2019, nr. 1(63), pp. 47-52. ISSN 1121-760X. DOI: https://doi.org/10.4081/ejh.2019.3010
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
European Journal of Histochemistry
Numărul 1(63) / 2019 / ISSN 1121-760X

VEGF, VEGF165b and EG-VEGF: Expression is specifically related with hormone profile in pituitary adenomas

DOI:https://doi.org/10.4081/ejh.2019.3010

Pag. 47-52

Corlan Ana Silvia1, Cimpean Anca-Maria1, Melnic Eugen2, Raica Marius1, Sârb Simona1
 
1 Victor Babes University of Medicine and Pharmacy, Timişoara,
2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 7 octombrie 2019


Rezumat

Vascular endothelial growth factor (VEGF), its inhibitory splice variant, VEGF165b and Endocrine Gland derived VEGF (EG-VEGF) have a controversial role in pituitary gland. We aim to study VEGF, VEGF165b and EG-VEGF expression in pituitary adenomas. A significant correlation was found between growth hormone (GH) and VEGF secretion (P=0.024). For prolactinomas, VEGF and prolactin expression, had a P-value of 0.02 for Kendall coefficient and a P-value of 0.043 for the Spearman coefficient. VEGFmRNA amplification was detected in both tumor cells and folliculostellate cells. VEGF165b was positive in 16.66% of pituitary adenomas. EG-VEGF was significantly correlated with prolactin (P=0.025) and luteinizing hormone (P=0.028). Our data strongly support VEGF, VEGF165b and EG-VEGF as important players of pituitary adenomas tumorigenesis. Particular hormonal milieu heterogeneity, special vascular network with an unusual reactivity to tumor growth correlated with variability of VEGF, VEGF165b and EG-VEGF secretion may stratify pituitary adenomas in several molecular groups with a direct impact on therapy and prognosis.

Cuvinte-cheie
angiogenesis, EG-VEGF, Pituitary adenomas, VEGF VEGF165b